These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Renal function after autologous bone marrow transplantation in children: a long-term prospective study. Frisk P, Bratteby LE, Carlson K, Lönnerholm G. Bone Marrow Transplant; 2002 Jan; 29(2):129-36. PubMed ID: 11850707 [Abstract] [Full Text] [Related]
4. Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment. Miralbell R, Sancho G, Bieri S, Carrió I, Helg C, Brunet S, Martin PY, Sureda A, Gomez De Segura G, Chapuis B, Estorch M, Ozsahin M, Keller A. Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):809-16. PubMed ID: 14967438 [Abstract] [Full Text] [Related]
6. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies. Wu DP, Milpied N, Moreau P, Mechinaud-Lacroix F, Mahe B, Le Tortorec S, Rapp MJ, Bourdin S, Mahe JM, Harousseau JL. Bone Marrow Transplant; 1994 Nov 01; 14(5):751-7. PubMed ID: 7889008 [Abstract] [Full Text] [Related]
8. Autologous bone marrow transplantation for patients with acute myeloblastic leukemia in relapse after autologous blood stem cell transplantation. de la Rubia J, Sanz GF, Martín G, Sempere A, Picón I, Carral A, Larrea L, Martínez J, Soler MA, Bonanad S, López F, Jarque I, Sanz MA. Bone Marrow Transplant; 1996 Dec 01; 18(6):1167-73. PubMed ID: 8971390 [Abstract] [Full Text] [Related]
10. Is veno-occlusive disease incidence influenced by the total-body irradiation technique? Belkacémi Y, Ozsahin M, Rio B, Laporte JP, Leblond V, Pène F, Laugier A. Strahlenther Onkol; 1995 Dec 01; 171(12):694-7. PubMed ID: 8545791 [Abstract] [Full Text] [Related]
11. Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation. Lawton CA, Cohen EP, Murray KJ, Derus SW, Casper JT, Drobyski WR, Horowitz MM, Moulder JE. Bone Marrow Transplant; 1997 Dec 01; 20(12):1069-74. PubMed ID: 9466280 [Abstract] [Full Text] [Related]
14. Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation. Spitzer TR, Cottler-Fox M, Torrisi J, Cahill R, Greenspan A, Lynch M, Deeg HJ. Bone Marrow Transplant; 1989 Sep 01; 4(5):559-65. PubMed ID: 2676044 [Abstract] [Full Text] [Related]
15. Renal dysfunction after total-body irradiation. Significance of selective renal shielding blocks. Igaki H, Karasawa K, Sakamaki H, Saito H, Nakagawa K, Ohtomo K, Tanaka Y. Strahlenther Onkol; 2005 Nov 01; 181(11):704-8. PubMed ID: 16254705 [Abstract] [Full Text] [Related]
17. Cataracts after autologous bone marrow transplantation in children. Frisk P, Hagberg H, Mandahl A, Söderberg P, Lönnerholm G. Acta Paediatr; 2000 Jul 01; 89(7):814-9. PubMed ID: 10943964 [Abstract] [Full Text] [Related]
18. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma. Brown JR, Yeckes H, Friedberg JW, Neuberg D, Kim H, Nadler LM, Freedman AS. J Clin Oncol; 2005 Apr 01; 23(10):2208-14. PubMed ID: 15753460 [Abstract] [Full Text] [Related]
19. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide. Duerst RE, Horan JT, Liesveld JL, Abboud CN, Zwetsch LM, Senf ES, Constine LS, Raubertas RF, Passarell JA, DiPersio JF. Bone Marrow Transplant; 2000 Mar 01; 25(5):489-94. PubMed ID: 10713624 [Abstract] [Full Text] [Related]